Issue 41 / 26 October 2015

THOUSANDS of researchers faced a nervous wait for the announcement last week of this year’s crop of successful grants awarded by the NHMRC.
The wait was made even more acute than in the past because of declining success rates with research applications — which have fallen to around 13% this year — and the increasing unpredictability of peer review.
There are a number of problems that have led to this situation.
The first is fiscal. Although a shift to longer 5-year grants was welcome, it has had the unintended consequence of falling foul of the 3-year limitation on forward commitments required by government, so that the available funds are (temporarily) squeezed.
The second problem is demographic. There has been a large increase in the size of the academic community in recent years, driven by the expansion of universities and the medical research sector, which means many more applicants.
The third is related. A larger demographic, almost by definition, means that the average quality of the academic population — and by extension the quality of the peer review system — is regressing to the mean, that is, towards mediocrity.
The fourth is salami slicing. Much of the funding for medical research is doled out in the form of “project” grants. Project grants inhibit expansive thinking, require a narrow focus, and are subject to nitpicking, which encourages risk-averse short-term proposals in the first place.
The avalanche of grant applications also creates enormous pressure on the system, not only by the unproductive use of investigators’ and reviewers’ time (and churning), but also the attendant problem of securing enough qualified people to undertake the mammoth task of grant review and selection.
This increases the likelihood of less experienced and less intellectually incisive reviewers being involved, and therefore of ad hoc outcomes, compounding the third and fourth problems above.
How do we fix this arthritic system, and how do we identify, encourage and support those researchers who could be capable of changing the world?
First, we should shift the emphasis to funding people, based on the excellence of their track record and the potential of their vision. This can be done by reducing the number of project and multi-researcher program grants, and introducing “personal program grants” (PPGs) of 5‒7 years duration to provide gifted individuals with a stable platform so they can be brave and expansive with their ideas.
This was argued recently in submissions to the NHMRC by the Association of Australian Medical Research Institutes and by the Garvan Institute. We suggested five levels of PPGs, with annual individual grants funding ranging from $200 000 to $1 million per annum.
The Canadian equivalent of the NHMRC, the Canadian Institutes of Health Research, has recently committed 45% of its funding to its Foundation Scheme, providing up to $1.5 million per grant per year for 7 years for established investigators and 5 years for new/early career investigators.
The structure of the peer-review system also needs to be overhauled. The one I favour is that used in the past at the Human Frontier Science Program. All applications in the basket were considered by a large (> 30) panel of highly accomplished investigators, each of whom had to read and independently rate them (A, B, C or D) before meeting together to consider ranking.
About 10% of applications were rated A by most if not all of the panel, so were funded as excellent, unless someone wanted to challenge the conventional wisdom. No crapshoot there.
An interesting minority were rated as A by half of investigators and D by the other half (terrific or terrible), which was where the really innovative proposals were. What a discussion followed!
It is time to clear the decks, and replace a struggling, out-of-date NHMRC research funding system with a new approach that empowers outstanding researchers and potential researchers, and directs limited future-building resources to the most transformative ends.
Professor John Mattick is the executive director of the Garvan Institute of Medical Research, Sydney.


Should medical research funding be directed more to gifted individuals with a track record than to specific projects?
  • Maybe – would need careful scrutiny (42%, 41 Votes)
  • Yes – it encourages new discoveries (31%, 30 Votes)
  • No – current system works (27%, 26 Votes)

Total Voters: 97

Loading ... Loading ...

6 thoughts on “John Mattick: Be brave

  1. Dr Ian Relf says:

    We already have jobs for good researchers- they are called University lecturers and associate professors and so on. Problem is they have to do a lot of poorly remunerated teaching and degree student supervision to keep their jobs when they want to do research. The good teachers stay on to help the students who are starved of lecturers. Gradually each new system is ‘gamed’ and then we need a new set of rules to get rid of the game players who use the system to get ahead; while the best reserachers get on with the real work- and the hangers on get their name on the paper and get equal credit. From the outside this looks confusing. Problem is, it looks confusing from the inside!



  2. Catherine cole says:

    The research dollar is further diluted by competition from clinical researchers. Basic scientists and discovery researchers already live on paltry NHMRC salaries without competing with clinicians who should embed research in their normal practice.

  3. john roy says:

    catherine i would love to embed a phd and then a postdoc followed by a lifelong research interest into my everyday clinical practice, but the reality is that public medicine in australia is funded for service delivery, not teaching or research

    i agree that it does seem unfair that clinicians get funded (and at a slightly higher rate too) through the same stream as scientists, but how else to encourage us to go into research? employ more clinicians and reduce clinical workload like usa/canada? set up a separate funding stream?

    but first the system needs more money. maybe gina, twiggy et al could donate to universities instead of tv stations…



  4. Susan Smith says:

    Catherine, it is also worth considering that clinical and translation research is the whole point of doing the basic & discovery sciences (in health). I have worked in both areas and each is as important as the other. Also, researchers working in a clinical setting often do not get funded at all for the research they do, but fit it into their lunch times and after hours and researchers privileged enough to have a bone fide research position are funded at  the lowest level and would be grateful for an NHMRC rate. It’s easy to think that some other group is getting a disproportionate share, but really all research in Australia is suffering badly.

  5. Susan Smith says:

    AusHSI (Australian centre for health services innovation) has suggested using an EOI process (3 pages per application vs 15) as a first step to shortlist projects. This would save $66 million per year and 500 years of researchers time for Australia’s research community.

  6. Kevin Runions says:

    I take issue with your quiz – Disagreeing with your proposal for “gifted individuals” to take the lion’s share is not equivalent to saying the current system works.  

Leave a Reply

Your email address will not be published.